Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Clinical Lung Cancer|September 1, 2015
Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung CancerLeonard T Ong, Mark Dunphy, Amanda Foster, et al.Clinical Lung Cancer|November 26, 2015
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for SurveillanceDaniel E Spratt, Abraham J Wu, Victoria Adeseye, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Clinical characteristics and course of 63 patients with BRAF mutant lung cancersAnya M Litvak, Paul K Paik, Kaitlin M Woo, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal CancerKaryn A Goodman, Diana Julie, Andrea Cercek, et al.Annals of Surgery|January 7, 2017
Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy LobectomyHao-Xian Yang, Kaitlin M Woo, Camelia S Sima, et al.BMC Cancer|May 25, 2019
Collagen organization of renal cell carcinoma differs between low and high grade tumorsSara L Best, Yuming Liu, Adib Keikhosravi, et al.Abdominal Radiology (New York)|February 17, 2018
Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization aloneAmanda R Smolock, Mircea M Cristescu, Audrey Hinshaw, et al.Acta Oncologica (Stockholm, Sweden)|June 7, 2018
Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)Donata von Reibnitz, Fauzia Shaikh, Abraham J Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer CenterTroy Z Horvat, Nelly G Adel, Thu-Oanh Dang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell TumorsDarren R Feldman, James Hu, Tanya B Dorff, et al.Pageof 6